Pre-earnings options volume in Ginkgo Bioworks is 1.6x normal with calls leading puts 10:3. Implied volatility suggests the market is anticipating a move near 10.1%, or 14c, after results are released. Median move over the past eight quarters is 7.2%.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on DNA:
- Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results
- Ginkgo Bioworks, Zymtronix announce partnership
- Ginkgo Bioworks to lead pathogen monitoring program at Kigali Airport, Rwanda
- Cathie Wood Gets Back on Track; Here Are 2 Stocks She’s Snapping Up
- Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs
